✨ Medicines Classification




10 JULY

NEW ZEALAND GAZETTE

2065

  • self-injection; except in medicines containing 300 micrograms or less per litre or per kilogram

  • Atropine methonitrate

  • Benorylate

  • Benzocaine; for internal use; for external use in medicines containing more than 10%

  • Benzydamine; for internal use

  • Bexarotene

  • Butacaine

  • Butyl aminobenzoate; except in medicines for dermal use containing 2% or less

  • Cinchocaine; for ophthalmic use; for external use in medicines containing more than 0.5%

  • Clindamycin

  • Colestyramine

  • Darbepoetin

  • Datura spp; except for oral use when specified elsewhere in the Schedule; except in datura stramonium or datura tatula for smoking or burning

  • Dextrorphan

  • Dicyclomine

  • Digoxin-specific antibody fragment

  • Diperodon

  • Drotrecogin

  • Duboisia leichhardtii; except when specified elsewhere in the Schedule

  • Duboisia myoporides; except when specified elsewhere in the Schedule

  • Ephedra

  • Epoetins

  • Etidocaine

  • Ezetimibe

  • Folic acid; for injection

  • Folinic acid; for injection

  • Gefitinib

  • Glatiramer acetate

  • Glyceryl trinitrate; for injection; for transdermal use; except in medicines containing 100 micrograms or less per litre or per kilogram

  • Guaiphenesin; except for oral use in medicines containing 2% or less or 200 milligrams or less

  • Homatropine

  • Hyaluronic acid; for injection except in intraocular viscoelastic products

  • Hyoscine; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

  • Hyoscine butylbromide; except when specified elsewhere in the Schedule

  • Hyoscyamine; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less per litre or per kilogram

  • Hyoscyamus niger; except when specified elsewhere in the Schedule; except in medicines containing 300 micrograms or less of total solanaceous alkaloids per litre or per kilogram

  • Hypromellose; for injection except in intraocular viscoelastic products

  • Ibritumomab tiuxetan

  • Insulins

  • Levetiracetam

  • Levosimendan

  • Lignocaine; for oral use except in throat lozenges containing 30 milligrams or less per dose form; for ophthalmic use

  • except when used in practice by a registered optometrist; for injection except when used as a local anaesthetic in practice by a registered nurse or podiatrist or by a dental therapist; for external use in medicines containing more than 10%

  • Memantine

  • Nicoumalone

  • Nitrofurazone

  • Nux vomica

  • Podophyllum emodi; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin

  • Podophyllum peltatum; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 20% of podophyllin

  • Podophyllotoxin; for internal use; for external use for the treatment of anogenital warts; for other external use in medicines containing more than 1%

  • Poractant alfa

  • Pramocaine

  • Pregnenolone

  • Prilocaine; for injection except when used as a local anaesthetic by a dental therapist; except when specified elsewhere in the Schedule

  • Prochlorperazine; except when specified elsewhere in the Schedule; except when sold for the treatment of nausea associated with emergency contraception by pharmacists or nurses accredited to sell levonorgestrel for emergency contraception

  • Propantheline

  • Protamine sulfate

  • Quinisocaine

  • Sabadilla; except when specified elsewhere in the Schedule

  • Sodium picosulfate; in oral laxative preparations

  • Strychnos spp

  • Thiomesterone

  • Thiourea; except in medicines containing 0.1% or less

  • Vardenafil

Schedule 2

Restricted Medicines

  • Diclofenac; in solid dose form containing 25 milligrams or less and more than 12.5 milligrams per dose form in packs of not more than 30 tablets or capsules
  • Erythryl tetranitrate
  • Glyceryl trinitrate; for oral or sublingual use
  • Hyoscine butylbromide; for oral use in medicines containing not more than 10 milligrams per dose form and in packs containing not more than 20 tablets or capsules
  • Isosorbide dinitrate; for oral use in medicines containing 10 milligrams or less per dose form
  • Mannityl hexanitrate
  • Podophyllum emodi; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin
  • Podophyllum peltatum; for external use for the treatment of warts other than anogenital warts in medicines containing 20% or less and more than 10% of podophyllin
  • Podophyllotoxin; for external use for the treatment of warts other than anogenital warts in medicines containing 1% or less and more than 0.5%
  • Prochlorperazine; in packs containing not more than 10 tablets for the treatment of nausea associated with migraine or emergency contraception


Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2003, No 78


Gazette.govt.nz PDF NZ Gazette 2003, No 78





✨ LLM interpretation of page content

πŸ₯ Classification of Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
Medicines, Classification, Prescription, Restricted, Pharmacy-only